Barclays PLC Gilead Sciences, Inc. Put Options Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Put Options

23 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 15, 2024
BUY
$66.59 - $83.99 $8.5 Million - $10.7 Million
127,600 New
127,600 $10.7 Million
Q1 2024

May 15, 2024
SELL
$71.58 - $87.29 $5.41 Million - $6.6 Million
-75,600 Reduced 37.43%
126,400 $9.26 Million
Q4 2023

Feb 15, 2024
SELL
$73.27 - $83.09 $9.42 Million - $10.7 Million
-128,600 Reduced 38.9%
202,000 $16.4 Million
Q3 2023

Nov 07, 2023
SELL
$73.94 - $80.67 $8.7 Million - $9.49 Million
-117,600 Reduced 26.24%
330,600 $24.8 Million
Q2 2023

Aug 03, 2023
BUY
$76.01 - $86.7 $15.2 Million - $17.4 Million
200,600 Added 81.02%
448,200 $34.5 Million
Q1 2023

May 04, 2023
BUY
$77.31 - $88.08 $19.1 Million - $21.8 Million
247,600 New
247,600 $20.5 Million
Q4 2021

Feb 14, 2022
BUY
$64.88 - $73.64 $31.6 Million - $35.8 Million
486,400 Added 94.45%
1,001,400 $72.7 Million
Q3 2021

Nov 09, 2021
BUY
$67.69 - $73.03 $11.5 Million - $12.4 Million
170,000 Added 49.28%
515,000 $36 Million
Q2 2021

Aug 13, 2021
BUY
$63.47 - $69.35 $20 Million - $21.8 Million
315,000 Added 1050.0%
345,000 $23.8 Million
Q1 2021

May 13, 2021
SELL
$60.0 - $68.46 $4.69 Million - $5.35 Million
-78,200 Reduced 72.27%
30,000 $1.94 Million
Q3 2020

Nov 12, 2020
SELL
$62.1 - $78.08 $99,360 - $124,928
-1,600 Reduced 1.46%
108,200 $6.84 Million
Q2 2020

Aug 12, 2020
SELL
$72.34 - $84.0 $49 Million - $56.9 Million
-677,500 Reduced 86.05%
109,800 $8.45 Million
Q1 2020

May 13, 2020
BUY
$62.63 - $80.22 $11.9 Million - $15.2 Million
189,900 Added 31.79%
787,300 $58.9 Million
Q4 2019

Feb 10, 2020
BUY
$61.62 - $67.78 $2.01 Million - $2.21 Million
32,600 Added 5.77%
597,400 $38.8 Million
Q3 2019

Nov 14, 2019
BUY
$62.51 - $69.0 $10.1 Million - $11.2 Million
162,100 Added 40.25%
564,800 $35.8 Million
Q2 2019

Aug 14, 2019
SELL
$61.87 - $69.38 $8.88 Million - $9.96 Million
-143,600 Reduced 26.29%
402,700 $27.2 Million
Q1 2019

May 15, 2019
SELL
$62.53 - $70.05 $6.73 Million - $7.54 Million
-107,600 Reduced 16.46%
546,300 $35.5 Million
Q4 2018

Feb 14, 2019
SELL
$60.54 - $79.0 $11 Million - $14.4 Million
-182,500 Reduced 21.82%
653,900 $40.9 Million
Q3 2018

Nov 14, 2018
BUY
$71.28 - $78.92 $11.8 Million - $13.1 Million
165,800 Added 24.72%
836,400 $64.6 Million
Q2 2018

Aug 14, 2018
BUY
$64.88 - $75.68 $8.22 Million - $9.59 Million
126,700 Added 23.29%
670,600 $47.5 Million
Q1 2018

May 15, 2018
SELL
$72.84 - $88.8 $40 Million - $48.7 Million
-548,500 Reduced 50.21%
543,900 $41 Million
Q4 2017

Feb 14, 2018
BUY
$71.15 - $83.52 $9.93 Million - $11.7 Million
139,600 Added 14.65%
1,092,400 $78.3 Million
Q3 2017

Nov 14, 2017
BUY
$72.11 - $85.47 $68.7 Million - $81.4 Million
952,800
952,800 $77.2 Million

Others Institutions Holding GILD

# of Institutions
1,923
Shares Held
994M
Call Options Held
10.5M
Put Options Held
9.75M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email